Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020
November 08, 2020 at 03:05 pm EST
Share
Nang Kuang Pharmaceutical Co., Ltd. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was TWD 424.833 million compared to TWD 469.769 million a year ago. Operating income was TWD 45.165 million compared to TWD 70.509 million a year ago. Net income was TWD 29.386 million compared to TWD 60.436 million a year ago. Basic earnings per share was TWD 0.29 compared to TWD 0.6 a year ago. For the nine months, sales was TWD 1,327.072 million compared to TWD 1,263.115 million a year ago. Operating income was TWD 176.642 million compared to TWD 157.966 million a year ago. Net income was TWD 135.714 million compared to TWD 137.135 million a year ago. Basic earnings per share was TWD 1.34 compared to TWD 1.37 a year ago.
NANG KUANG PHARMACEUTICAL CO., LTD. is principally engaged in the manufacture, processing and trading of western medicine. The company main products include injections, sterile injections, powder injections, hard capsules, bare ingots, film ingots, casing ingots, granules and creams, among others. The Company is also engaged in the manufacture, processing and trading of medical equipment. The Company distributes its products within the domestic market and to overseas markets.
NANG KUANG PHARMACEUTICAL CO., LTD. 
